Skip to content
CancerIndex

Publication

Psoralidin inhibits stemness-associated characteristics in cervical cancer cells via modulation of Oct4/Sox2 expression.

Tanya Tripathi, Shivam Kumar, Udit Joshi, Apoorva Chaudhary, Divya Janjua, Neha Tanwar, Aastha Mittal, Anna Senrung, Alok Chandra Bharti

Naunyn-Schmiedeberg's archives of pharmacologySep 16, 2026PMID 42744918doi:10.1007/s00210-026-05823-7 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 19, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260919-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Resistance to chemo/radio therapy, along with recurrence of aggressive tumors, is a major factor contributing to cervical cancer (CaCx) mortality. This is largely driven by a small subset of slow-growing cancer stem cells (CSC). The present study aimed to explore the potential of psoralidin to…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.